Reviews
Average rating: 3/5
Physician ( 1 )
-
5
-
4
-
3
-
2
-
1
Average rating: 3.00/5
Total Reviews: 1
-
5
-
4
-
3
-
2
-
1
Pegloticase is a third-line treatment for chronic, refractory gout, used when standard urate-lowering therapies like allopurinol or febuxostat fail or are not tolerated. It is highly effective but can cause serious side effects such as infusion reactions and anaphylaxis, requiring close monitoring and premedication. The treatment is expensive, with costs exceeding $30,000 per month, though financial assistance programs may help offset the price for eligible patients.
0